Cargando…
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020
A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estim...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459271/ https://www.ncbi.nlm.nih.gov/pubmed/32762796 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001369 |
_version_ | 1783576338188206080 |
---|---|
author | Bogogiannidou, Zacharoula Vontas, Alexandros Dadouli, Katerina Kyritsi, Maria A Soteriades, Soteris Nikoulis, Dimitrios J Mouchtouri, Varvara Α Koureas, Michalis Kazakos, Evangelos I Spanos, Emmanouil G Gioula, Georgia Ntzani, Evangelia E Eleftheriou, Alexandros A Vatopoulos, Alkiviadis Petinaki, Efthimia Papaevangelou, Vassiliki Speletas, Matthaios Tsiodras, Sotirios Hadjichristodoulou, Christos |
author_facet | Bogogiannidou, Zacharoula Vontas, Alexandros Dadouli, Katerina Kyritsi, Maria A Soteriades, Soteris Nikoulis, Dimitrios J Mouchtouri, Varvara Α Koureas, Michalis Kazakos, Evangelos I Spanos, Emmanouil G Gioula, Georgia Ntzani, Evangelia E Eleftheriou, Alexandros A Vatopoulos, Alkiviadis Petinaki, Efthimia Papaevangelou, Vassiliki Speletas, Matthaios Tsiodras, Sotirios Hadjichristodoulou, Christos |
author_sort | Bogogiannidou, Zacharoula |
collection | PubMed |
description | A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early measures. |
format | Online Article Text |
id | pubmed-7459271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-74592712020-09-03 Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 Bogogiannidou, Zacharoula Vontas, Alexandros Dadouli, Katerina Kyritsi, Maria A Soteriades, Soteris Nikoulis, Dimitrios J Mouchtouri, Varvara Α Koureas, Michalis Kazakos, Evangelos I Spanos, Emmanouil G Gioula, Georgia Ntzani, Evangelia E Eleftheriou, Alexandros A Vatopoulos, Alkiviadis Petinaki, Efthimia Papaevangelou, Vassiliki Speletas, Matthaios Tsiodras, Sotirios Hadjichristodoulou, Christos Euro Surveill Rapid Communication A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early measures. European Centre for Disease Prevention and Control (ECDC) 2020-08-06 /pmc/articles/PMC7459271/ /pubmed/32762796 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001369 Text en This article is copyright of the authors or their affiliated institutions, 2020. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Rapid Communication Bogogiannidou, Zacharoula Vontas, Alexandros Dadouli, Katerina Kyritsi, Maria A Soteriades, Soteris Nikoulis, Dimitrios J Mouchtouri, Varvara Α Koureas, Michalis Kazakos, Evangelos I Spanos, Emmanouil G Gioula, Georgia Ntzani, Evangelia E Eleftheriou, Alexandros A Vatopoulos, Alkiviadis Petinaki, Efthimia Papaevangelou, Vassiliki Speletas, Matthaios Tsiodras, Sotirios Hadjichristodoulou, Christos Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 |
title | Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 |
title_full | Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 |
title_fullStr | Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 |
title_full_unstemmed | Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 |
title_short | Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 |
title_sort | repeated leftover serosurvey of sars-cov-2 igg antibodies, greece, march and april 2020 |
topic | Rapid Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459271/ https://www.ncbi.nlm.nih.gov/pubmed/32762796 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001369 |
work_keys_str_mv | AT bogogiannidouzacharoula repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT vontasalexandros repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT dadoulikaterina repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT kyritsimariaa repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT soteriadessoteris repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT nikoulisdimitriosj repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT mouchtourivarvaraa repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT koureasmichalis repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT kazakosevangelosi repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT spanosemmanouilg repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT gioulageorgia repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT ntzanievangeliae repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT eleftherioualexandrosa repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT vatopoulosalkiviadis repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT petinakiefthimia repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT papaevangelouvassiliki repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT speletasmatthaios repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT tsiodrassotirios repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 AT hadjichristodoulouchristos repeatedleftoverserosurveyofsarscov2iggantibodiesgreecemarchandapril2020 |